Skip to main content
CRIS logo

Curis, Inc.

CRISNASDAQHealthcareBiotechnology

$0.41Today:- (-)1Y −67.01%

As of Oct 16, 2026 close

Market cap
$990.11K
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.50$15.80
Volume (live)
-
Avg. volume (3M)
224.59K

Curis (CRIS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Curis used $27.20M of cash in operating activities. Free cash flow was −$27.20M.

Curis Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Curis, Inc. (CRIS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Mar 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-7.58-43.39-43.39-47.41-56.67-45.44-29.91-32.14-32.58-53.32
Depreciation & Amortization0.170.190.200.260.230.160.140.130.180.24
Deferred Income Tax0.000.00-0.000.001.400.020.000.010.00
Stock Based Compensation4.025.935.936.006.755.282.702.663.945.36
Change in Working Capital1.75-3.72-3.722.78-6.821.000.62-1.56-1.50-0.72
Change in Accounts Receivable-1.03-0.56-0.560.180.25-0.180.20-0.380.21-0.61
Change in Inventory0.000.00-0.000.000.000.000.001.87-49.93
Change in Accounts Payable2.55-2.08-2.083.34-3.884.971.000.06-1.87-0.38
Change in Other Working Capital0.24-1.081.43-0.741.82-0.03-0.58-1.24-1.7150.19
Other Operating Activities-25.561.431.43-0.061.82-0.030.654.71-0.110.09
Net Cash from Operating Activities-27.20-39.56-39.56-38.43-54.34-37.62-25.74-26.21-30.07-48.36
Investing Activities
Capital Expenditures0.000.00-0.00-0.420.00-0.68-0.04-0.09-0.19
Acquisitions0.000.00-0.000.000.000.000.000.090.19
Purchases of Investments0.00-18.10-18.10-70.34-62.00-93.13-48.37-11.47-26.74-51.12
Sales/Maturities of Investments0.0047.5447.54108.1395.4445.235.087.0548.2047.68
Other Investing Activities2.500.00-0.000.000.000.000.00-0.09-0.19
Net Cash from Investing Activities2.5029.4429.4437.7933.02-47.90-49.05-4.4621.37-3.63
Financing Activities
Debt Repayment-5.59-8.59-0.00-4.980.000.8923.20-6.1021.74
Common Stock Issued15.3512.0212.0214.125.840.30176.510.070.1441.55
Other Financing Activities-5.590.00-8.59-6.54-4.98-4.4711.420.000.140.95
Net Cash from Financing Activities9.773.443.447.580.87-4.17188.8123.27-5.9664.24
Summary
Effect of Forex Changes on Cash0.000.00-0.000.090.000.00-0.660.000.00
Net Change in Cash-14.94-6.68-6.686.93-20.45-89.69114.03-8.05-14.6512.25
Cash at Beginning of Period20.5427.2327.2320.2940.74130.4316.4023.6438.2926.04
Cash at End of Period5.6120.5420.5427.2320.2940.74130.4315.5823.6438.29
Free Cash Flow-27.20-39.56-39.56-38.43-54.75-37.62-26.42-26.25-30.15-48.54
Supplemental Disclosures
Interest Paid--0.462.364.114.445.05---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Curis Cash Flow

What is Curis's free cash flow?

Curis had negative free cash flow of $27.20M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Curis pay dividends or buy back shares?

Curis's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition